GENMAB A/S - SPONSORED ADS (GMAB)

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / SPONSORED ADS
Total 13F shares
73,215,280
Share change
+11,589,906
Total reported value
$2,255,247,248
Put/Call ratio
64%
Price per share
$30.80
Number of holders
286
Value change
+$357,194,936
Number of buys
184
Number of sells
79

Institutional Holders of GENMAB A/S - SPONSORED ADS (GMAB) as of Q4 2025

As of 31 Dec 2025, GENMAB A/S - SPONSORED ADS (GMAB) was held by 286 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,215,280 shares. The largest 10 holders included Orbis Allan Gray Ltd, ALLIANCEBERNSTEIN L.P., Paradigm Biocapital Advisors LP, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, Harding Loevner LP, MORGAN STANLEY, FIRST TRUST ADVISORS LP, and GOLDMAN SACHS GROUP INC. This page lists 286 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.